Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies
Journal of the American Society for Mass Spectrometry · 2024
DOI: 10.1021/jasms.4c00308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2024. Verfasst von Xiaoxiao Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Chemistry, Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707, United States. Hauptthemen laut MEDLINE: Sulfhydryl Compounds, Antibodies, Monoclonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals.
Abstract (Originalsprache)
Cysteine residues are crucial for the formation of conserved disulfide bonds in therapeutic monoclonal antibodies (mAbs), which are essential for their folding and structural stability. The presence of free thiols in mAbs can indicate incomplete disulfide bond formation, potentially impacting the molecule's conformational stability. Free thiol quantitation has been achieved using labeling-based strategies such as maleimide and haloalkyl derivatives at both intact and peptide levels. However, intact-level measurement only provides total free thiol levels, while peptide-level measurement is time-consuming and more prone to assay-induced artifacts. In this study, we present a novel label-free HILIC-MS method that separates free thiol species at the subunit level, followed by free thiol localization by the MS2 fragmentation pattern. This allows for facile identification and quantitation of intrachain free thiols at domain-specific resolution. Compared to bottom-up approaches, this subunit HILIC-MS method excels in simpler sample preparation and higher throughput and enables chain-specific free thiol analysis for bispecific mAbs. This method can be readily applied for screening mAb candidates with elevated levels of free thiols in early-stage developability assessment and facilitating an effective comparability evaluation of mAb samples during process development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Analytical Chemistry, Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707, United States.
ORCID-Profile: Xiaoxiao Huang, Shunhai Wang
Förderung
- Regeneron Pharmaceuticals
Zitieren
APA
Huang, X., Wang, X., Cotham, V. C., Bramhall, D., Zhong, J., Zhao, Y., Qiu, H., Wang, S., & Li, N. (2024). Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00308
Vancouver
Huang X, Wang X, Cotham VC, Bramhall D, Zhong J, Zhao Y, et al. Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.4c00308
BibTeX
@article{Huang2024,
author = {Huang, Xiaoxiao and Wang, Xin and Cotham, Victoria C and Bramhall, David and Zhong, Jieqiang and Zhao, Yimeng and Qiu, Haibo and Wang, Shunhai and Li, Ning},
title = {Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2024},
doi = {10.1021/jasms.4c00308}
}
EUVIMED